Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score < 1, 1-19, and >= 20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis

Autor:	Burtness, Barbara Rischin, Danny Greil, Richard Soulieres, Denis Tahara, Makoto de Castro, Gilberto Psyrri, Amanda and Baste, Neus Neupane, Prakash Bratland, Ase Fuereder, Thorsten Hughes, Brett G. Mesia, Ricard Ngamphaiboon, Nuttapong Rordorf, Tamara Ishak, Wan Zamaniah Wan Ge, Joy and Swaby, Ramona Gumuscu, Burak Harrington, Kevin
Jazyk:	angličtina
Rok vydání:	2020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::5e897e9efe843fe2564e06c1e06cd8c8 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3191694 Zobrazit plný text záznamu